Background: The major concern regarding the use of low-dose oral minoxidil (LDOM) for the treatment of hair loss is the potential risk of systemic adverse effects.
Objective: To describe the safety of LDOM for the treatment of hair loss in a large cohort of patients.
Methods: Retrospective multicenter study of patients treated with LDOM for at least 3 months for any type of alopecia.